IIT Bombay Alum Karthik Shekhar Wins Camille Dreyfus Award
IIT Bombay‑educated Karthik Shekhar, a professor at UC Berkeley, wins the Camille Dreyfus Teacher‑Scholar Award for pioneering work on bioelectricity and neural communication.
1958, Mumbai- Second IIT on 545-acre Powai campus near lakes. UNESCO-assisted, it leads in computer science, quantum research, and entrepreneurship. Hosts 14,000+ students, 65,000 alumni, and recent sustainability center with Honeywell.
IIT Bombay‑educated Karthik Shekhar, a professor at UC Berkeley, wins the Camille Dreyfus Teacher‑Scholar Award for pioneering work on bioelectricity and neural communication.
IIM Mumbai partners IIT Bombay to offer 70-seat UG program in Digital Science & Business Management via JEE Main, at ₹6-7L/year.
Lab0 founder Lakshya Gupta publicly calls out Rocketlane CEO for excluding his YC-backed startup from Propel event over competition.
IIT Mandi’s new MI-RA lab drives indigenous multimodal AI through TIHs, fostering datasets and deep-tech for healthcare, agriculture, and governance.
IIT Goa and EcoEx ink MoU to fuse academia with industry expertise, driving research, innovation, and training for India’s green goals and net-zero ambitions.
An IIT Bombay grad’s post contrasts Bengaluru’s negotiation-heavy interactions with Mumbai’s easygoing service, igniting a fiery online debate among netizens.
IIT Bombay scientists develop DNA aptamers blocking bacterial resistance enzymes, reviving common antibiotics to fight deadly drug-resistant infections.
IIT Bombay has developed an in‑house biomass gasification system that converts campus leaf waste into clean cooking fuel, cutting LPG use and carbon emissions while boosting energy resilience.
CBDT Notifications 40-43/2026 approve IIT Bhilai, IIT Bombay, and Indian Rubber Materials Research Institute for tax-deductible donations under IT Act Section 35(1)(ii).
IIT Bombay researchers Prof Ruchi Anand and Prof P I Pradeepkumar developed DNA aptamers – short synthetic nucleic acid strands – to block bacterial resistance enzymes, resensitizing drug-resistant pathogens to existing antibiotics. Unlike developing new drugs, this practical approach leverages known antibiotic safety profiles while addressing the global antimicrobial resistance crisis through stable, modifiable aptamers.